Just the Facts on Geron Corporation (GERN)

Geron Corporation (GERN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $3.29, down from yesterday’s close by -4.08%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Geron Corporation (GERN) currently trades with a market capitalization of $586.41 Million. That value represents a market adjusting for revenues that have been falling by -40.78 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$20.62 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.05 on a per share basis this quarter. Perhaps, that suggests something about why 3.12% of the outstanding share supply is held by institutional investors.

Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Geron Corporation recorded a 52-week high of $6.68. It is now trading 3.39% off that level. The stock is trading $3.83 its 50-day moving average by 0.54%. The stock carved out a 52-week low down at $1.74.

In recent action, Geron Corporation (GERN) has made a move of -12.03% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.61, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 25.07% with $159.78 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of GERN.

Previous articleThe Case for and Against Abbott Laboratories (ABT)
Next articleDigging Up the Facts on Patterson-UTI Energy, Inc. (PTEN)